Skip to main content

Use of molecular typing to investigate bacterial translocation from the intestinal tract of chlorpyrifos-exposed rats



Human are confronted on a daily basis with contaminant pesticide residues in food, water and other components of the environment. Although the digestive system is the first organ to come into contact with food contaminants, very few data are available on the impact of low-dose pesticide exposure during the in utero and postnatal periods on intestinal bacterial translocation (BT). Previous studies have revealed that chlorpyrifos (CPF) exposure is associated with intestinal dysbiosis and the contamination of sterile organs. Here, molecular typing was used to investigate intestinal bacterial translocation in rats exposed to chlorpyrifos in utero and during lactation. The translocated bacteria were profiled, and CPF tolerance and antibiotic resistance traits were determined.


A total of 72 intestinal segments and extra-intestinal organs were obtained from 14 CPF-exposed rats. The samples were cultured to isolate bacterial strains that had tolerated treatment with 1 or 5 mg CPF/kg bodyweight/day in vivo. Strains were identified using matrix-assisted laser desorption/ionization (MALDI) Biotyper. The disk diffusion method was used to determine the antibiotic susceptibility. The isolates were genotyped with PCR assays for the enterobacterial repetitive intergenic consensus sequence and random amplification polymorphic DNA.


Bacterial translocation was confirmed for 7 of the 31 strains (22.6 %) isolated from extra-intestinal sites. Overall, the most prevalent bacteria were Staphylococcus aureus (55.5 % of the 72 intestinal and extra-intestinal isolates), Enterococcus faecalis (27.7 %) and Bacillus cereus (9.8 %). 5 % of the S. aureus isolates displayed methicillin resistance. Seventy two strains were identified phenotypically, and seven translocated strains (mainly S. aureus) were identified by genotyping. Genotypically confirmed translocation was mainly observed found in pesticide-exposed groups (6 out of 7).


BT from the intestinal tract colonized normally sterile extra-intestinal organs in CPF-exposed rats. Our findings validate the use of molecular typing for the assessment of intestinal BT in CPF-exposed rats during critical periods of development.


Highly toxic organophosphorus compounds are the main constituents of many of the agricultural, industrial, and residential insecticides used worldwide. The acute toxicity associated with high doses of organophosphorus pesticides is caused by inhibition of acetylcholinesterase and the resulting increase in synaptic acetylcholine levels [1]. However, there is substantial evidence to show that this mechanism alone cannot account for the wide range of harmful effects associated with organophosphorus pesticides—especially when the level of exposure is below the threshold for acute toxicity [2].

Chlorpyrifos (CPF) is a major organophosphorus insecticide. It is used to treat fruit and vegetable crops and exists as chlorpyrifos ethyl [the most toxic form: O,O-diethyl-O-(3,5,6-trichloro-2-pyridyl)-phosphorothionate; chemical formula: C9H11Cl3NO3PS] and chlorpyrifos methyl.

Although CPF residues can be found in cereals, fruit, vegetables and (potentially) meat and drinking water, few studies have focused on the compound’s putative impact on the digestive tract. Tirelli et al. [3] have shown that CPF increases membrane permeability in an enterocyte cell culture model. Furthermore, Joly Condette et al. [4] showed for the first time that low-dose chlorpyrifos exposure in vivo causes morphological changes in the intestinal epithelium, alters intestinal permeability and increases bacterial translocation (BT, as detected by culture-based methods). In rats, this phenomenon is associated with (and probably caused by) failure of the intestine’s barrier function and an imbalance of in the intestinal microbiota [5].

The intestinal microbial community is a complex ecosystem that influences the host’s physiology in many ways. The bacterial count in the caecum and colon reaches values of 1012/g in the feces, whereas nearby portal blood, mesenteric lymph nodes (MLNs) and organs (like kidney, liver, spleen) are usually sterile. This illustrates the efficacy of this intestinal barrier.

Berg has defined BT as the migration of microorganisms and their toxins from the intestinal lumen to sterile organs such as the MLNs, blood, and abdominal organs [6]. BT can lead to a local inflammatory response and a potential increase in intestinal permeability, which in turn can lead to systemic infection and multiple organ failure [7]. Arnold and Brody were the first to confirm the harmfulness of BT in animals [6, 8]. In humans, some degree of BT is observed in Crohn’s disease, neutropenia, hemorrhagic shock, necrotizing enterocolitis, delayed sepsis, systemic inflammatory response syndrome, and multi-organ failure [9, 10]. Reduced blood flow in the gut, trauma, chronic inflammation, and immunosuppression are all factors that enhance BT [11].

BT from the intestine is most commonly detected by measuring the presence of viable bacteria in extra-intestinal target tissues. This reflects not only the integrity of the mucosal barrier function but also the numbers and types of microbes in the lumen. Translocation may occur by three mechanisms: (i) through microfold cells [12] (a normal processing pathway that is especially active during specific life periods, including the neonatal period) [1315]; (ii) through intestinal epithelial cells (a major pathway after cellular injury such as that caused by cytotoxic drugs) [16], and (iii) after bacterial overgrowth and/or impairment of host defenses [7].

Since the digestive system appears to be a target for CPF and the only study on BT in this context was based on conventional microbiological tests, we repeated our original study by using molecular techniques to investigate intestinal BT (to the liver, spleen, MLNs, Peyer’s patches, and kidney) in CPF-exposed rats, identify specific bacterial strains, and confirm the bacteria’s intestinal origin.

Lastly, we sought to determine whether prolonged, low-dose exposure to CPF for different periods of time promotes the emergence of antibiotic-resistant bacterial strains in rats.


Experimental animals and housing

All animal experiments were approved by the Animal Care and Use Committee at Jules Verne University of Picardy (Amiens, France: reference #2011/A/1).

The laboratory animals used in this study (15 female and 5 male Wistar Hannover rats; age on delivery: 8 weeks; body weight range: 215–300 g) were obtained from Janvier Labs (Le Genest-Saint-Isle, France). The rats were allowed to acclimatize to the laboratory for at least one week period prior to the experiment. The animals were housed in plastic cages and fed a diet of standard rat pellets. Water was provided ad libitum. The protocol has been described previously [4].

Schedule for CPF treatment

After the acclimation period, female rats were mated with males (two females per male). Once a positive smear was observed, dams received daily doses of the respective treatment from days 0 to 21 (D21, the day of weaning) by oral gavage. Three exposure groups were studied: the rats in the CPF0 (control) group received 1 mL/kg bodyweight (BW) of rapeseed oil; the rats in the CPF1 group received 1 mg/kg BW/day of CPF in rapeseed oil, and the rats in the CPF5 group received 5 mg/kg BW/day of CPF in rapeseed oil. The rats in the litters were studied at two time points: firstly at weaning (after having been exposed to CPF in the dam’s milk (D21: CPF0, n = 7; CPF1, n = 8, and CPF5, n = 6) and secondly in young adulthood (after the young rats had been gavaged with CPF individually from weaning to the age of 60 days (D60: CPF0, n = 5; CPF1, n = 7, and CPF5, n = 8).

Definition of BT

In an individual rat, BT was defined as the presence of the same bacterial species [with identical or closely related enterobacterial repetitive intergenic consensus (ERIC2) sequence and random amplification polymorphic DNA (RAPD) patterns in PCR assays] in both the intestinal segments and the normally sterile extra-intestinal organs.

Tissue cultures

The tissue specimens obtained from each rat were separately mashed, dilacerated, and homogenized in 9 mL of Ringer’s solution in a sterile lab blender bag (Stomacher®, Seward Medical Ltd, Worthing, UK). Next, 1 mL of the homogenate was diluted to one tenth of its original concentration (1:10). 100 μL volume of each diluted homogenate was inoculated onto aerobic and anaerobic Columbia blood agar, chocolate agar, and Chapman agar plates (bioMérieux, Marcy l’Etoile, France), which were incubated at 35 ± 2 °C in 5 % CO2 for 24–72 h. Isolates grown from samples (i.e. each colony) were numbered and identified on the basis of their characteristic colonial and microscopic appearances and matrix-assisted laser desorption/ionization time-of-flight mass spectrometry (MALDI–TOF-MS) pattern.

Definition of duplicates

Rats that produced more than one positive sample for the same bacterium with the same phenotypic expression of antibiotic susceptibility were assessed only once. Hence, duplicates were excluded from the study.

Bacterial identification by MALDI Biotyper

A MALDI–TOF-MS system (Autoflex III, Bruker Daltonics, Billerica, MA, USA) was used to examine each unique colony of microorganisms isolated by culture, according to a previously described procedure [1719]. In brief, samples were prepared with absolute ethanol, and 1 μL of matrix solution (2,5-dihydroxybenzoic acid 50 mg/mL, 30 % acetonitrile, 0.1 % trifluoroacetic acid) was added. The analytical data were processed with Bruker Biotyper software (version 2.0, Bruker Daltonics), as described previously [20]. Identifications were performed in duplicate, according to the manufacturer’s instructions.

Antibiotic susceptibility testing

As recommended by the Comité de l’Antibiogramme de la Société Française de Microbiologie [21], the disk diffusion method (with Mueller–Hinton agar at 35 ± 2 °C for 24 h) was used to test the bacterial isolates’ antibiotic susceptibility. Staphylococcus aureus and Staphylococcus warneri were tested for susceptibility to the following 20 antibiotics: streptomycin (10 µg), kanamycin (30 μg), gentamicin (30 μg), tobramycin (30 μg), fosfomycin (50 μg), doxycycline (30 μg), trimethoprim–sulfamethoxazole (1.25 + 23.75 μg), erythromycin (Er: 15 μg), lincomycin (L: 15 μg), pristinamycin (PT: 15 μg), rifampin (30 μg), ofloxacin (OFX: 5 μg), vancomycin (30 μg), teicoplanin (30 μg), linezolid (10 μg), fusidic acid (10 μg), benzylpenicillin (PEN: 6 μg), oxacillin (OXA: 5 μg), cefoxitin (FOX: 30 μg), and moxalactam (30 μg). Enterococcus faecalis was tested for susceptibility to ampicillin (10 μg), kanamycin (1000 μg), gentamicin (500 μg), streptomycin (500 μg), Er (15 μg), L (15 μg), PT (15 μg), teicoplanin (30 μg), vancomycin (30 μg), trimethoprim–sulfamethoxazole (1.25 + 23.75 μg), and linezolid (10 μg). The isolates were classified as susceptible (S), intermediate (I) and resistant (R) on the basis of established breakpoint values [21].

Determination of the bacterial strains’ clonality

Total nucleic acids were extracted from bacteria grown on Columbia agar supplemented with 5 % sheep blood incubated at 35 ± 2 °C for 18–24 h. Each a bacterial colony was suspended in 300 μL of distilled water, transferred to 1.5 μL microfuge tubes, and incubated at 95 °C for 10 min. The cell suspension was incubated in a bath-type ultrasonic sonicator (Gen-Probe; bioMérieux, Craponne, France) for 15 min and then centrifuged at 13,500 rpm for 10 min. A 400 μL aliquot of eluate was carefully transferred to a new sterile Eppendorf tube and stored at −20 °C until use in the polymerase chain reaction (PCR) assays. PCR was performed in a final volume of 50 μL of the corresponding ready-to-use Master Mix buffer from the TopTaq Master Mix Kit (Qiagen, Venlo, Netherlands). Each reaction mixture contained 25 μL of Master Mix buffer, 20 μM of ERIC2 primer (5′-AAG-TAA-GTG-ACT-GGG-GTG-AGC-G-3′) [22] or 20 μM of RAPD1 PRIMER (5′-GCT-TGG-GTG-AGA-ATT-GCA-GG-3′) [23], with 1.5 μL of DNA for ERIC2 and 2 μL of DNA for RAPD) used as a template, and 5 μL of colored loading buffer for each PCR.

The amplification conditions for ERIC2-PCR were as follows: 7 min at 94 °C, followed by 45 cycles of 1 min at 94 °C, 1 min at 45 °C, and 2 min at 72 °C, with a final extension of 7 min at 72 °C. The conditions for RAPD-PCR were as follows: 3 min at 94 °C, followed by 45 cycles of 1 min at 94 °C, 1 min at 36 °C, and 5 min at 72 °C, with a final extension of 7 min at 72 °C. All PCRs were carried out in a GeneAmp 2400 thermal cycler (Perkin Elmer Inc., Waltham, MA, USA).

PCR products were resolved by electrophoresis on a 1 % agarose gel in Tris–acetate-EDTA (Sigma-Aldrich, USA) containing 0.5 μg/mL of ethidium bromide. SmartLadders® (200–10 kb; Eurogentec, Seraing, Belgium) were used as molecular weight markers. The gel profiles were photographed with an ultraviolet light transilluminator (ChemiDoc Touch Imaging System, Bio-Rad Laboratories, Marnes-la-Coquette, France) and processed with Image Lab software (version 5.2.1, Bio-Rad).

Statistical analysis

All statistical analyses were performed with R software (version 3.1.0; Lucent Technologies, Murray Hill, NJ, USA).

The frequency of BT was quoted with its 95 % confidence interval (CI, calculated using the “minlike” method) [17]. A mixed logistic regression model was used to determine the relationships between the likelihood of BT on one hand and exposure and age on the other. The odds ratio (OR) [95 % CI] for BT was also calculated. The threshold for statistical significance was set to p < 0.05.


Microbiological tests

Out of a total of 126 cultured tissue samples, 46 were negative and 80 were positive. After eliminating duplicates (see below), 72 positive samples (40 intestinal fragments and 32 samples from extra-intestinal organs) were studied.

When considering the 72 samples from various sites (Table 1), S. aureus was the most commonly identified organism (n = 40 positive samples, 55.5 %), followed by E. faecalis at (n = 20, 27.7 %), Bacillus cereus (n = 7, 9.8 %), S. warneri (n = 3, 4.2 %) and Micrococcus luteus (n = 2, 2.8 %).

Table 1 Distribution of bacterial strains by sample type (n = 72)

Antibiotic susceptibility

The susceptibility results showed that 38 of the 40 S. aureus isolates (95 %) were methicillin-susceptible, and 2 (5 %) were resistance to methicillin and OFX (i.e. methicillin-resistant S. aureus, MRSA).

All S. warneri, B. cereus and M. luteus isolates were susceptible to the antibiotics tested with the Staphylococcus genus, except for two strains of S. warneri that were resistant to fusidic acid and Er.

For E. faecalis, all isolates were susceptible to ampicillin, vancomycin, teicoplanin and trimethoprim–sulfamethoxazole, and all were resistant to L. The E. faecalis isolates showed a low-to-moderate level of resistance to Er [11 out of 20 were susceptible (55 %) and 9 (45 %) were resistant] and PT [14 were susceptible (70 %) and 6 were resistant (30 %)].


We isolated 72 strains of S. aureus, E. faecalis and B. cereus from samples collected from 14 rats. The strains were compared with each other by using ERIC2-PCR and RAPD-PCR assays. The other species (S. warneri and M. luteus) found in samples from three rats (animal ID numbers: 19.9, 15.8 and 3.8) were not typed because of their lower prevalence.

The S. aureus isolates were compared in an ERIC2-PCR analysis (n = 40). A total of 28 distinct ERIC2-PCR types were detected (referred to as E1 through E28). ERIC2-PCR types E21, E22, and E25 included four isolates each (isolates 24, 25, 38 and 40 for E21; isolates 26, 27, 34, and 35 for E22, and isolates 30–33 for E25). Within each profile, the isolate were genetically related. Two isolates each were found for E9 (isolates 9 and 10), E15 (isolates 16 and 17), and E16 (isolates 18 and 20).

The remaining profiles included one isolate each. In an RAPD-PCR analysis, the 40 S. aureus isolates were differentiated into 12 distinct types (referred to as R1 through R12). The nucleic acids of two isolates (1 and 2) could not be studied because the strain was not sufficiently viable. The following RAPD types had genetically identical isolates within each profile: R2 consisted of seven identical isolates (isolates 4, 17, 19, 21, 23, 25 and 27), R3 consisted of six identical isolates (5–7 and 9–11), R8 consisted of five identical isolates (18, 20, 22, 24, and 26), R11 consisted of four identical isolates (30–33), R12 consisted of three identical isolates (34–36), R10 consisted of three identical isolates (37–39), R6 consisted of two identical isolates (13 and 14), and R7 consisted of two identical isolates (15 and 16) (Fig. 1a, b).

Fig. 1

a ERIC-PCR profiles for S. aureus: Lines 1–40 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs (bp). The 40 isolates were differentiated into 28 distinct ERIC-PCR patterns (E1–E28). b RAPD-PCR profiles for S. aureus: Lines 3–40 isolate numbers (above gels), and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs (bp). The 38 isolates were differentiated into 12 distinct types (R1–R12)

ERIC2- and RAPD-PCRs were then used to evaluate the relatedness of B. cereus isolates (n = 7). Four patterns were generated with the ERIC primer (denoted by E1 through E4): E4 included four isolates (48–50), E1 included two isolates (44 and 45), and one isolate each was found for patterns E2 (isolates 46) and E3 (isolates 47). RAPD-PCR revealed three profiles (designated as R1 through R3): four genetically indistinguishable isolates were found for the profiles R1 (44–46) and R3 (48–50). The R2 pattern was considered to be an unrelated type (isolate 47) (Fig. 2a, b).

Fig. 2

a ERIC-PCR profiles for B. cereus: Lines 44–50 isolate numbers (above gels) and pattern types (below gels). The seven isolates were differentiated into four distinct types (E1–E7). b RAPD-PCR profiles for B. cereus: Lines 44–50 isolate numbers (below gels). The seven isolates were differentiated into three distinct types (R1–R3)

ERIC2-PCRs of E. faecalis isolates (n = 20) revealed ten patterns (denoted by E1 through E10). Pattern E6 comprised five isolates (58–61 and 63), pattern E9 comprised four isolates (65, 66, 71, and 72), pattern E10 comprised three isolates (67–69), and pattern E2 comprised two isolates (64 and 70). Within each profile, all the isolates were genetically identical. The remaining patterns (E1, E5 and E7) consisted of one isolate each.

RAPD-PCRs of E. faecalis generated 13 distinct profiles (denoted by R1 through R13). Three isolates each were found for the patterns R5 (58, 59 and 60) and R11 (67, 68 and 69). Patterns R2 (isolates 54 and 62), R3 (isolates 55 and 56), and R13 (isolates 71 and 73) comprised two isolates each. Within each profile, all the isolates were genetically identical. The remaining profiles included one genetically unrelated isolate each (Fig. 3a, b).

Fig. 3

a ERIC-PCR profiles for E. faecalis: Lines 53–72 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs (bp). The 20 isolates were differentiated into ten distinct types (E1–E10). b RAPD-PCR profiles for E. faecalis: Lines 53–72 isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are expressed in SmartLadder base pairs. (bp). The 20 isolates were differentiated into 13 distinct type (R1–R13)

Assessment of genetic groups

The combination of S. aureus isolates obtained with ERIC2-PCR and RAPD-PCR enabled us to define 34 genetic groups (Ggs, denoted by A through Z and AA through JJ). Gg DD (patterns E25-R11) included four isolates (30–33), whereas two isolates each were found for GgI (9 and 10 for patterns E9-R3), GgQ (18 and 20 for patterns E16-R8), and Gg EE (38 and 40 for patterns E21-R12). Within each Gg, all the isolates were genetically identical. The other Ggs comprised one isolate each and were considered to be unrelated.

The combined typing results for B. cereus strains revealed four Ggs (denoted by A through D). GgA included two isolates (44 and 45) and GgD consisted of three isolates (48–50). Within each group, these isolates were genetically similar to each other. One isolate each was determined for GgB (46) and GgC (47); these isolates were considered to be unrelated.

Combining the ERIC2-PCR and RAPD-PCR patterns for E. faecalis gave 16 Ggs (referred to as I through XVI). The strains in each group (isolates 58–60, Gg VI), (isolates 67–69, Gg XIII), and (isolates 71 and 72, Gg XVI) were genetically related. The remaining groups included one isolate each and showed polyclonal heterogeneity.

Bacterial translocation

Translocation was observed in 7 of the 31 CPF-exposed strains (22.6 %, with a 95 % CI of [7–36 %]; Table 2). Five were detected at D21 and 2 were detected at D60; one belonged to the CPF0 group, 3 (42.9 %) belonged to the CPF1 group and the remaining 3 (42.9 %) belonged to the CPF5 group (Fig. 4a, b).

Table 2 Isolates for which bacterial translocation was confirmed (7 out of 31 isolates)
Fig. 4

Translocated isolates. a ERIC-PCR profiles for S. aureus [lines (9, 10), (18, 20), (30, 31), (32, 33), (38, 40)]; B. cereus (lines 48, 49), and E. faecalis (lines 58, 59): isolate numbers (above gels) and pattern types (below gels). Molecular weights (MW) are expressed in base pairs (pb). b RAPD-PCR profiles for S. aureus [lines (9, 10), (18, 20), (30, 31), (32, 33), (38, 40)]; B. cereus (48, 49); and E. faecalis (58, 59): isolate numbers (above gels) and pattern types (below gels). Seven isolates (as defined genotypically) were found to have translocated

Of the 24 BT-free rats, 8 (33.4 %) belonged to the CPF0 group, 10 (41.6 %) belonged to the CPF1 group, and 6 (25 %) belonged to the CPF5 group; 16 (66.6 %) were detected at D21 and 8 (33.4 %) were detected at D60 (Table 3). Translocation increase with CPF exposure (OR [95 % CI] = 1.25 [0.22–7.15]), although this was not statistically significant (p = 0.7981). Furthermore, translocation was more likely on D21 than on D60 (OR [95 % CI] = 1.25 [0.22–7.15]); again, the OR was not statistically significant (p = 0.7981).

Table 3 Isolates for which bacterial translocation was not confirmed (24 out of 31 isolates)

The bacteria that had translocated from the intestinal tract and were detected in the extra-intestinal samples were distributed as follows: 5 of the 40 S. aureus isolates (12.5 %) from the caecum (n = 4) or the colon (n = 1) had translocated to the kidneys (n = 3), adipose tissue (n = 1) or Peyer’s patches (n = 1). One of the 20 E. faecalis isolates (5 %) from the caecum had translocated to the liver, and one of the 7 B. cereus isolates (14.2 %) from the ileum had translocated to the kidneys (Table 2). The typing assay results confirmed these data. By combining the ERIC2-PCR and RAPD-PCR patterns, we found that 14 isolates were included in six genetic groups: GgII (isolates 9 and 10), GgQ (isolates 18 and 20), GgDD (isolates 30–33), and GgEE (isolates 38 and 40) for S. aureus; GgD (isolates 48 and 49) for B. cereus; and GgVI (isolates 58 and 59) for E. faecalis—indicating that (i) these isolates were involved in the translocation process and (ii) the isolates within each Gg were clonally related.


Although molecular typing has often been used to characterized BT in a clinical setting [24, 25], there are few literature data on the use of these techniques to detect translocation from the intestinal tract in animal models [26]. To the best of our knowledge, the present study is the first to have employed molecular typing (ERIC2-PCR and RAPD-PCR) techniques in the detection of BT in the rat. We observed BT during critical life periods in 22.5 % of the studied CPF-exposed rats. In studies of rats with ascites and carbon-tetrachloride-induced cirrhosis, the prevalence of BT ranged from 36.8 to 97.6 % [2730]. In a clinical study, positive MLN cultures were found for 32.1 % of patients with cirrhosis [31].

These findings indicate that the prevalence of BT depends on the type of study and the detection methods used (bacteriological culture of MLN samples). It has been reported that bacterial DNA in the biological fluids is a marker for BT in rats with cirrhosis [28, 31]; this suggests that the definition of BT has been widened to the passage of bacterial fragments (endotoxins, bacterial DNA, etc.) from the intestinal lumen to the MLNs and into the circulatory system in general. Although they came from the same species, translocated strains and non-translocated strains differed clearly in terms of the ERIC2-PCR and RAPD-PCR patterns (77.5 % of strains). As reported in the literature [26], we concluded that BT did not occur in samples when the extra-intestinal organs (liver, spleen, Peyer’s patches, MLNs, adipose tissue, and kidneys) were sterile. One could argue that the intestinal bacteria found in the extra-intestinal tissue samples resulted from bacterial contamination and not from BT. Table 3 shows that 41.5 % (22 out of 53) of the isolates in the extra-intestinal tissues were not found in intestinal tissues. Conversely, 58.5 % (31 out of 53) of the isolates in intestinal tissues were absent from extra-intestinal samples. This discrepancy might have been due to slight differences between the intestinal bacterial counts in rats with BT vs. rats without BT. Our results contradicts the literature data on BT in animal models, in which bacterial overgrowth was identified as a major BT-promoting factor [32]. In rats, anaerobic bacteria predominate in the ileum, caecum and colon. This anaerobic flora rarely translocates, and thus limits the colonization and growth of potentially translocating bacteria. The intestinal mucosa thus constitutes a barrier against BT via the transcellular route (through enterocytes) or the paracellular route (at tight junctions). Studies in animals have shown that some antibiotics (such as norfloxacin and trimethoprim–sulfamethoxazole) selectively reduce intestinal bacterial overgrowth (and thus BT) by changing the composition of the bacterial flora. In a cirrhotic rat model, the administration of propranolol or cisapride stimulated intestinal motility by speeding up intestinal transit, decreasing bacterial overgrowth, improving intestinal permeability and reducing BT. Similarly, the administration of conjugated biliary acids (cholylsarcosine and cholylglycine) suppressed intestinal bacterial overgrowth and reduced BT. Lastly, the use of antioxidants alone or in combination with probiotics (Lactobacillus) in cirrhotic rats reduced the intestinal bacterial load, BT, and oxidative stress in the intestinal wall.

Several previous studies have investigated the effect of CPF on the intestinal wall (ileum and colon) [4, 5]. Exposure to CPF decreases the mRNA expression of genes encoding the tight junction proteins (including claudin-4 and zonula-1); this increases intestinal permeability, enables BT and activates the immune system. In the present study, all the bacterial strains isolated from individual samples from CPF-exposed rats were found to be viable on agar plates, which suggests that the strains tolerated CPF doses of 1 mg/kg BW and 5 mg/kg BW in vivo. All of the isolates were then tested for their susceptibility to 20 antibiotics. Over 90 % of the detected bacterial strains were susceptible; 2 strains (5 %) of S. aureus expressed the MRSA phenotype (PENr OXAr FOXr) but were susceptible to the remaining antibiotics, 9 isolates (45 %) of E. faecalis were resistant to Er, 6 isolates (30 %) were resistant to PT, and 100 % of the isolates were resistant to L (natural resistance). For E. faecalis, 3 isolates (15 %) expressed the macrolide-lincosamide-streptogramin B (MLSB) + streptogramin A (SA) phenotype (ErrLrPTr), and 12 isolates (60 %) expressed the MLSB phenotype (ErrLrPTs). In strains expressing the MLSB phenotype, the genes encoding resistance are located on a 20–30 kb plasmid [33]. However, resistance is chromosome-encoded in the majority of strains isolated in France [33]. Resistance to macrolide, lincosamide, SA (PT) and SB (virginiamycin) is associated with the production of an SA-inactivating mutant acetyltransferase and an SB-inactivating mutant hydrolase [3436]. Expression of the MRSA phenotype and susceptibility to other antibiotics has been documented in the literature [17, 3740].

Methicillin resistance is associated with a specific mechanism in which a mobile genetic element [the staphylococcal cassette chromosome (SCC) mec] integrates into the S. aureus chromosome. In the S. aureus chromosome, the mec A gene encodes a specific, methicillin-resistant transpeptidase (penicillin-binding protein 2a) [38], which results in resistance to all β-lactam antibiotics (due to a low affinity for binding to β-lactam). The classic mecA gene codes for resistance to methicillin, kanamycin, gentamicin (in most cases), tobramycin, amikacin, Er, and L but not for resistance to PT and OFX. A new mecA homolog mecB strain (N315) [37, 38] and a mecC strain (LGA256) [39, 40] have been identified. The SCC elements classified as mecB or mecC share ≥70 % nucleotide sequence identity with the classic mecA gene. In the present study, the isolates were phenotypically resistant to all β-lactams but remained susceptible to other tested antibiotics and thus corresponded chromosomally to the mecC gene. Our results are in agreement with the literature data [17, 3740]. When considering the genotyped strains, resistant strains (B. cereus and E. faecalis) were only found in the CPF groups (both CPF1 and CPF5)—particularly in juvenile rats at D21. Naphade et al. [41] detected 9.8 and 26.2 kDa plasmids in bacterial cultures from garden soil, indicating that the ability to tolerate high concentrations of heavy metal salts, pesticides and antibiotics is a plasmid-encoded characteristic. Harishankar et al. [42] study of five model intestinal bacteria found that Lactobacillus fermentum, Lactobacillus lactis, and Escherichia coli tolerated high concentrations of CPF (>1400 µg/mL), whereas E. faecalis and Lactobacillus plantarum tolerated lower concentrations (400 and 100 μg/mL, respectively).

The three most tolerant bacteria (L. fermentum, L. lactis, and E. coli) produced an organophosphorus phosphatase that degrades CPF; the concentration of CPF was higher outside the cells (i.e. in the supernatant) than inside the cells. L. fermentum degraded 70 % of the CPF (with 3,5,6-trichloro-2-pyridinol as the end product), L. lactis degraded up to 61 % of the CPF (with CPF oxon as the end product), whereas E. coli degraded only 16 % of the CPF (with CPF oxon and diethylphosphate as the end products). This microbial variation in pesticide tolerance was dependent on the end-product degradation profiles and/or the types of end products [43, 44]. Shafiani and Malik [44] reported that a Pseudomonas spp. isolated from soil was able to tolerate up to 800 μg/mL of endosulfan, 1600 μg/mL of carbofuran and 1600 μg/mL of malathion. All of the bacterial isolates were further tested for their antibiotic susceptibility to seven different antibiotics. A bacteriological analysis of endosulfan-exposed soil by Sepperumal et al. [45] revealed the presence of Bacillus ciradans, Pseudomonas spp., Bacillus lentus, Acinetobacter spp., and B. cereus. Additional plasmid-curing experiments were performed to determine whether pesticide resistance traits in these bacteria were encoded on a plasmid or on the bacterial chromosome. Furthermore, B. ciradans and Acinetobacter spp. contained plasmids of 7 and 4 kb in size, respectively. Once BT has occurred, the isolation of viable bacteria in the liver, spleen, adipose tissue, MLNs and kidneys depends on (i) the immunological competence of the host and (ii) individual bacterial virulence factors that prevent the pathogen’s destruction [46].

We were unable to isolate anaerobic bacteria from the Enterobacteriaceae family; this constitutes a study limitation. In holoxenic rats, the stomach and bowel is mainly colonized from birth to weaning by Lactobacillus, Streptococcus and Enterococcus genera, where as Enterobacteriaceae and anaerobic bacteria are absent [47, 48]. After weaning, the pups’ bacterial flora downstream of the ileum and caecum predominantly consists of anaerobic bacteria [49]. These results are consistent with Raybaud et al. [44] observation of the absence of the Enterobacteriaceae family. However, our failure to isolate anaerobic bacteria was probably due to the detection technique used.

In conclusion, our earlier morphological and molecular analyses showed that long-lasting exposure to CPF (an organophosphate insecticide observed as food residues) altered the maturation of the rat intestine and was associated with intestinal dysbiosis and BT towards sterile organs [4, 5]. In the present study, we confirmed the occurrence of BT and validated the use of molecular typing in rats exposed to CPF in utero and during lactation.

The present study showed that molecular typing can detect intestinal BT in CPF-exposed rats; a combination of ERIC2-PCR and RAPD-PCR patterns can be used as a DNA fingerprint for intestinal microfloral strains. The most prevalent bacteria in intestinal samples from CPF-exposed rats were S. aureus, E. faecalis and B. cereus. Furthermore, chromosome- and plasmid-encoded pesticide-tolerance and antibiotic-resistance traits were observed in S. aureus and E. faecalis strains.

Lastly, we believe that our present findings provide strong evidence to show that early in utero and lactational exposure to CPF may have short- and long-lasting impacts on the digestive system. Importantly, CPF is found in cereals, fruit, vegetables and (potentially) in meat and drinking water, and is known to cross the placental barrier. Under normal circumstances, the intestinal epithelium acts as a barrier against food antigens and commensal bacteria. The latter bacteria live in symbiosis with the host and are significantly involved in physiological functions. The present data on gut homeostasis indicate that CPF disrupts the gut maturation, alters the bacterial equilibrium and enhances BT towards sterile organs. Moreover, the observed effect may be even greater during the food diversification period that occurs after weaning. Hence, we strongly believe that pesticide exposure in infancy (when the digestive system is still immature) should be avoided as much as possible.



bacterial translocation




confidence interval




control group






enterobacterial repetitive intergenic consensus 2


genetic groups








matrix-assisted laser desorption/ionization time-of-flight mass spectrometry


mesenteric lymph nodes


macrolide-lincosamide-streptogramin B


methicillin-resistance Staphylococcus aureus




odds ratio




polymerase chain reaction








random amplification polymorphic DNA


staphylococcal cassette chromosome






  1. 1.

    Ambali SF, Idris SB, Onukak C, Shittu M, Ayo JO. Ameliorative effects of vitamin C on short-term sensorimotor and cognitive changes induced by acute chlorpyrifos exposure in Wistar rats. Toxicol Ind Health. 2010;26:547–58.

    CAS  Article  PubMed  Google Scholar 

  2. 2.

    Middlemore-Risher ML, Adam BL, Lambert NA, Terry AV Jr. Effects of chlorpyrifos and chlorpyrifos-oxon on the dynamics and movement of mitochondria in rat cortical neurons. J Pharmacol Exp Ther. 2011;339:341–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  3. 3.

    Tirelli V, Catone T, Turco L, Di Consiglio E, Testai E, De Angelis I. Effects of the pesticide clorpyrifos on an in vitro model of intestinal barrier. Toxicol In Vitro. 2007;21:308–13.

    CAS  Article  PubMed  Google Scholar 

  4. 4.

    Joly Condette C, Khorsi-Cauet H, Morliere P, Zabijak L, Reygner J, Bach V, et al. Increased gut permeability and bacterial translocation after chronic chlorpyrifos exposure in rats. Plos ONE. 2014;9:e102217.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  5. 5.

    Joly Condette C, Bach V, Mayeur C, Gay-Queheillard J, Khorsi-Cauet H. Chlorpyrifos exposure during perinatal period affects intestinal microbiota associated with delay of maturation of digestive tract in rats. J Pediatr Gastroenterol Nutr. 2015;61:30–40.

    CAS  PubMed  Google Scholar 

  6. 6.

    Berg RD. Bacterial translocation from the gastrointestinal tract. Adv Exp Med Biol. 1999;473:11–30.

    CAS  Article  PubMed  Google Scholar 

  7. 7.

    Andersen K, Kesper MS, Marschner JA, Konrad L, Ryu M, Kumar Vr S, Kulkarni OP, Mulay SR, Romoli S, Demleitner J, Schiller P, Dietrich A, Müller S, Gross O, Ruscheweyh HJ, Huson DH, Stecher B, Anders HJ. Intestinal dysbiosis, barrier dysfunction, and bacterial translocation account for CKD-related systemic inflammation. J Am Soc Nephrol. 2016. doi:10.1681/ASN.2015111285.

  8. 8.

    Balzan S, de Almeida Quadros C, de Cleva R, Zilberstein B, Cecconello I. Bacterial translocation: overview of mechanisms and clinical impact. J Gastroenterol Hepatol. 2007;22:464–71.

    CAS  Article  PubMed  Google Scholar 

  9. 9.

    Swank GM, Deitch EA. Role of the gut in multiple organ failure: bacterial translocation and permeability changes. World J Surg. 1996;20:411–7.

    CAS  Article  PubMed  Google Scholar 

  10. 10.

    Chiodini RJ, Dowd SE, Galandiuk S, Davis B, Glassing A. The predominant site of bacterial translocation across the intestinal mucosal barrier occurs at the advancing disease margin in Crohn’s disease. Microbiology. 2016;162:1–2.

    Article  Google Scholar 

  11. 11.

    Plantefève G, Bleichner G. Translocation bactérienne: mythe ou réalité? Réanimation. 2001;10:550–61.

    Article  Google Scholar 

  12. 12.

    Mabbott NA, Donaldson DS, Ohno H, Williams IR, Mahajan A. Microfold (M) cells: important immunosurveillance posts in the intestinal epithelium. Mucosal Immunol. 2013;6:666–77.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  13. 13.

    Go LL, Ford HR, Watkins SC, Healey PJ, Albanese CT, Donhalek A, et al. Quantitative and morphologic analysis of bacterial translocation in neonates. Arch Surg. 1994;129:1184–90.

    CAS  Article  PubMed  Google Scholar 

  14. 14.

    Van Camp JM, Tomaselli V, Coran AG. Bacterial translocation in the neonate. Curr Opin Pediatr. 1994;6:327–33.

    PubMed  Google Scholar 

  15. 15.

    Yajima M, Nakayama M, Hatano S, Yamazaki K, Aoyama Y, Yajima T, et al. Bacterial translocation in neonatal rats: the relation between intestinal flora, translocated bacteria, and influence of milk. J Pediatr Gastroenterol Nutr. 2001;33:592–601.

    CAS  Article  PubMed  Google Scholar 

  16. 16.

    Sung H, Kim SW, Hong M, Suk KT. Microbiota-based treatments in alcoholic liver disease. World J Gastroenterol. 2016;22:6673–82.

    Article  PubMed  PubMed Central  Google Scholar 

  17. 17.

    Belmekki M, Mammeri H, Hamdad F, Rousseau F, Canarelli B, Biendo M. Comparison of Xpert MRSA/SA Nasal and MRSA/SA ELITe MGB assays for detection of the mecA gene with susceptibility testing methods for determination of methicillin resistance in Staphylococcus aureus isolates. J Clin Microbiol. 2013;51:3183–91.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  18. 18.

    Biendo M, Mammeri H, Pluquet E, Guillon H, Rousseau F, Canarelli B, et al. Value of Xpert MRSA/SA blood culture assay on the Gene Xpert(R) Dx System for rapid detection of Staphylococcus aureus and coagulase-negative staphylococci in patients with staphylococcal bacteremia. Diagn Microbiol Infect Dis. 2013;75:139–43.

    CAS  Article  PubMed  Google Scholar 

  19. 19.

    Carbonnelle E, Beretti JL, Cottyn S, Quesne G, Berche P, Nassif X, et al. Rapid identification of Staphylococci isolated in clinical microbiology laboratories by matrix-assisted laser desorption ionization-time of flight mass spectrometry. J Clin Microbiol. 2007;45:2156–61.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  20. 20.

    Seng P, Drancourt M, Gouriet F, La Scola B, Fournier PE, Rolain JM, et al. Ongoing revolution in bacteriology: routine identification of bacteria by matrix-assisted laser desorption ionization time-of-flight mass spectrometry. Clin Infect Dis. 2009;49:543–51.

    CAS  Article  PubMed  Google Scholar 

  21. 21.

    Comité de l’antibiogramme de la Société Française de Microbiologie (CA-SFM EUCAST). Détermination de la sensibilité aux antibiotiques, 2014.

  22. 22.

    Tzouvelekis LS, Tzelepi E, Prinarakis E, Gazouli M, Katrahoura A, Giakkoupi P, et al. Sporadic emergence of Klebsiella pneumoniae strains resistant to cefepime and cefpirome in Greek hospitals. J Clin Microbiol. 1998;36:266–8.

    CAS  PubMed  PubMed Central  Google Scholar 

  23. 23.

    Skibsted U, Baggesen DL, Dessau R, Lisby G. Random amplification of polymorphic DNA (RAPD), pulsed-field gel electrophoresis (PFGE) and phage-typing in the analysis of a hospital outbreak of Salmonella enteritidis. J Hosp Infect. 1998;38:207–16.

    CAS  Article  PubMed  Google Scholar 

  24. 24.

    Manan N, Chin Chin S, Abdullah N, Wan H. Differentiation of Lactobacillus-probiotic strains by visual comparison of random amplified polymorphic DNA (RAPD) profiles. Afr J Biotechnol. 2009;8:3964–9.

    Google Scholar 

  25. 25.

    Youssef M, Al Shurman A, Chachaty E, Bsoul AR, Andremont A. Use of molecular typing to investigate bacterial translocation from the intestinal tract in malnourished children with gram-negative bacteremia. Clin Microbiol Infect. 1998;4:70–4.

    CAS  Article  PubMed  Google Scholar 

  26. 26.

    van der Heijden KM, van der Heijden IM, Galvao FH, Lopes CG, Costa SF, Abdala E, et al. Intestinal translocation of clinical isolates of vancomycin-resistant Enterococcus faecalis and ESBL-producing Escherichia coli in a rat model of bacterial colonization and liver ischemia/reperfusion injury. Plos ONE. 2014;9:e108453.

    Article  CAS  PubMed  PubMed Central  Google Scholar 

  27. 27.

    Garcia-Tsao G, Lee FY, Barden GE, Cartun R, West AB. Bacterial translocation to mesenteric lymph nodes is increased in cirrhotic rats with ascites. Gastroenterology. 1995;108:1835–41.

    CAS  Article  PubMed  Google Scholar 

  28. 28.

    Guarner C, Gonzalez-Navajas JM, Sanchez E, Soriando G, Frances R, Chiva M, et al. The detection of bacterial DNA in blood of rats with CCl4-induced cirrhosis with ascites represents episodes of bacterial translocation. Hepatology. 2006;44:633–9.

    CAS  Article  PubMed  Google Scholar 

  29. 29.

    Guarner C, Runyon BA, Young S, Heck M, Sheikh MY. Intestinal bacterial overgrowth and bacterial translocation in cirrhotic rats with ascites. J Hepatol. 1997;26:1372–8.

    CAS  Article  PubMed  Google Scholar 

  30. 30.

    Llovet JM, Bartoli R, Planas R, Cabre E, Jimenez M, Urban A, et al. Bacterial translocation in cirrhotic rats. Its role in the development of spontaneous bacterial peritonitis. Gut. 1994;35:1648–52.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  31. 31.

    Such J, Frances R, Munoz C, Zapater P, Casellas JA, Cifuentes A, et al. Detection and identification of bacterial DNA in patients with cirrhosis and culture-negative, nonneutrocytic ascites. Hepatology. 2002;36:135–41.

    CAS  Article  PubMed  Google Scholar 

  32. 32.

    Berg RD. Bacterial translocation from the gastrointestinal tract. Trends Microbiol. 1995;3:149–54.

    CAS  Article  PubMed  Google Scholar 

  33. 33.

    El Solh N, Fouace JM, Pillet J, Chabbert YA. Plasmid DNA content of multiresistant Staphylococcus aureus strains. Ann Microbiol. 1981;132B:131–56.

    Google Scholar 

  34. 34.

    El Solh N, Fouace JM, Shalita Z, Bouanchaud DH, Novick RP, Chabbert YA. Epidemiological and structural studies of Staphylococcus aureus R plasmids mediating resistance to tobramycin and streptogramin. Plasmid. 1980;4:117–20.

    Article  PubMed  Google Scholar 

  35. 35.

    Le Goffic F, Capmau ML, Abbe J, Cerceau C, Dublanchet A, Duval J. Plasmid mediated pristinamycin resistance: PH 1A, a pristinamycin 1A hydrolase. Ann Microbiol. 1977;128B:471–4.

    Google Scholar 

  36. 36.

    Le Goffic F, Capmau ML, Bonnet D, Cerceau C, Soussy C, Dublanchet A, et al. Plasmid-mediated pristinamycin resistance. PAC IIA: a new enzyme which modifies pristinamycin IIA. J Antibiot. 1977;30:665–9.

    CAS  Article  PubMed  Google Scholar 

  37. 37.

    Garcia-Alvarez L, Holden MT, Lindsay H, Webb CR, Brown DF, Curran MD, et al. Meticillin-resistant Staphylococcus aureus with a novel mecA homologue in human and bovine populations in the UK and Denmark: a descriptive study. Lancet Infect Dis. 2011;11:595–603.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  38. 38.

    Ito T, Katayama Y, Hiramatsu K. Cloning and nucleotide sequence determination of the entire mec DNA of pre-methicillin-resistant Staphylococcus aureus N315. Antimicrob Agents Chemother. 1999;43:1449–58.

    CAS  PubMed  PubMed Central  Google Scholar 

  39. 39.

    Laurent F, Chardon H, Haenni M, Bes M, Reverdy ME, Madec JY, et al. MRSA harboring mecA variant gene mecC, France. Emerg Infect Dis. 2012;18:1465–7.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  40. 40.

    Stegger M, Andersen PS, Kearns A, Pichon B, Holmes MA, Edwards G, et al. Rapid detection, differentiation and typing of methicillin-resistant Staphylococcus aureus harbouring either mecA or the new mecA homologue mecA (LGA251). Clin Microbiol Infect. 2012;18:395–400.

    CAS  Article  PubMed  Google Scholar 

  41. 41.

    Naphade SR, Durve AA, Bhot M, Varghese J, Chandra N. Isolation, characterization and identification of pesticide tolerating bacteria from garden soil. Eur J Exp Biol. 2012;2:1943–51.

    CAS  Google Scholar 

  42. 42.

    Harishankar MK, Sasikala C, Ramya M. Efficiency of the intestinal bacteria in the degradation of the toxic pesticide, chlorpyrifos. 3 Biotech. 2013;3:137–42.

    Article  Google Scholar 

  43. 43.

    Kale SP, Murthy NB, Raghu K. Effect of carbofuran, carbaryl, and their metabolites on the growth of Rhizobium sp. and Azotobacter chroococcum. Bull Environ Contam Toxicol. 1989;42:769–72.

    CAS  Article  PubMed  Google Scholar 

  44. 44.

    Shafiani S, Malik A. Tolerance of pesticides and antibiotic resistance in bacteria isolated from wastewater-irrigated soil. World J Microbiol Biotechnol. 2003;19:897–901.

    CAS  Article  Google Scholar 

  45. 45.

    Sepperumal U, Palanimanickam A, Sivalingam G. Plasmid mediated endosulfan degradation by Bacillus ciradans and Acinetobacter species. J Microbiol Biotech Res. 2013;3:15–20.

    CAS  Google Scholar 

  46. 46.

    O’Boyle CJ, MacFie J, Mitchell CJ, Johnstone D, Sagar PM, Sedman PC. Microbiology of bacterial translocation in humans. Gut. 1998;42:29–35.

    Article  PubMed  PubMed Central  Google Scholar 

  47. 47.

    Ducluzeau R, Raibaud P. Les interactions bactériennes dans le tube digestif. Rev sci tech Off int Epiz. 1989;8:291–311.

    Article  Google Scholar 

  48. 48.

    Raibaud P, Ducluzeau R. Etude de la colonisation bactérienne du tractus gastro-intestinal à l’aide de modèles expérimentaux. Rev sci tech Off int Epiz. 1989;8:361–73.

    Article  Google Scholar 

  49. 49.

    Raibaud P, Dickison AB, Sacquet E, Charlier H, Mocquot G. La microflore du tube digestif du rat. II. Dénombrement de différents genres microbiens dans l’estomac et l’intestin de rats conventionnels. Variations quantitatives individuelles et en fonction de l’âge. Ann Inst Pasteur. 1966;110:861–76.

    CAS  Google Scholar 

Download references

Authors’ contributions

HKC was involved in the study design. MB and HKC designed the experiments, and devised and coordinated the study. CJC and HKC conducted in vivo experiments and took samples. FH extracted DNA and performed PCRs. BED was involved in the technical implementation of this study, the identification of isolates and processing of the rat data. MB and HKC performed the microbiological analysis and interpreted data. CJC, FH, MB and HKC wrote the paper. CJC, FH and HKC revised the manuscript. VB provided the equipment required to perform the study. HKC has primary responsibility for final content. All authors read and approved the final manuscript.


We thank Momar Diouf for assistance with the statistical analyses.

We also thank Dr. David Fraser (Biotech Communication SARL, Damery, France) for editorial assistance.

Competing interests

The authors declare that they have no competing interests.

Availability of data and materials

Data and materials are available from the corresponding author.

Ethics approval and consent to participate

All animal experiments were approved by the Animal Care and Use Committee at Jules Verne University of Picardy (Amiens, France: reference #2011/A/1).


This work was funded by the Jules Verne University of Picardy, the French Ministry of Research and the Picardy Regional Council. The funders had no roles in study design, data collection and analysis, decision to publish, or preparation of this manuscript.

Author information



Corresponding author

Correspondence to Hafida Khorsi-Cauet.

Rights and permissions

Open Access This article is distributed under the terms of the Creative Commons Attribution 4.0 International License (, which permits unrestricted use, distribution, and reproduction in any medium, provided you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons license, and indicate if changes were made. The Creative Commons Public Domain Dedication waiver ( applies to the data made available in this article, unless otherwise stated.

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Joly Condette, C., Elion Dzon, B., Hamdad, F. et al. Use of molecular typing to investigate bacterial translocation from the intestinal tract of chlorpyrifos-exposed rats. Gut Pathog 8, 50 (2016).

Download citation


  • Rat
  • Bacterial translocation
  • Chlorpyrifos
  • In utero
  • Lactational period
  • Intestinal permeability
  • Molecular typing